Dartmouth Health is the only health care system on the East Coast to be part of the newly launched Brain Health Navigator ...

Older studies estimated a lower risk of dementia. According to new research, the number of people living with the disease in ...

Alzheimer's disease begins with a long period during which abnormal amyloid and tau proteins build up in the brain without ...

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that ...

Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

Experts say there are ways to reduce our risk of dementia, including diet and exercise, protecting against hearing loss, and ...

The Davos Alzheimer’s Collaborative (DAC), a pioneering worldwide initiative seeking to cure Alzheimer’s disease and improve ...

Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer’s-related psychosis during the ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Leqembi's subcutaneous dosing allows Alzheimer's patients to administer weekly treatment at home in 15 seconds. Get Real-Time ...